Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$21.81 - $25.14 $2,748 - $3,167
-126 Reduced 5.05%
2,368 $55,000
Q4 2023

Feb 14, 2024

SELL
$14.29 - $25.95 $104,317 - $189,435
-7,300 Reduced 74.54%
2,494 $62,000
Q3 2023

Nov 09, 2023

BUY
$14.45 - $20.34 $60,921 - $85,753
4,216 Added 75.58%
9,794 $144,000
Q2 2023

Aug 09, 2023

BUY
$17.13 - $23.74 $805 - $1,115
47 Added 0.85%
5,578 $104,000
Q1 2023

May 12, 2023

SELL
$19.34 - $24.11 $55,138 - $68,737
-2,851 Reduced 34.01%
5,531 $124,000
Q4 2022

Feb 09, 2023

BUY
$12.64 - $25.52 $105,948 - $213,908
8,382 New
8,382 $212,000
Q2 2022

Aug 11, 2022

BUY
$8.95 - $19.24 $21,283 - $45,752
2,378 New
2,378 $36,000

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.